1. New drugs in Europe, 2012 EMCDDA–Europol 2012 Annual Report on the Implementation of Council Decision 2005/387/JHA, EMCDDA, 2012. file:///C:/Users/znalezij/Downloads/EMCDDA-Europol%202012%20Annual%20Report_final%20(3).pdf (accessed 17.07.14).
2. Synthetic cannabinoids in herbal products, Requests the United Nations Office on Drugs and Crime, n.d. https://www.unodc.org/documents/scientific/Synthetic_Cannabinoids.pdf (accessed 17.07.14).
3. Consideration of the major cannabinoid agonists, ACMD, n.d. http://forendex.southernforensic.org/uploads/references/Consideration_of_the_major_cannabinoid_agonists.pdf (accessed 17.07.14).
4. Spice and other herbal blends: harmless incense or cannabinoid designer drugs?;Auwärter;J. Mass Spectrom.,2009
5. Identification of a cannabinoid analog as a new type of designer drug in a herbal product;Uchiyama;Chem. Pharm. Bull. (Tokyo),2009